SCHEMBL7301720

SCHEMBL7301720

O=C(N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1ccoc1)OCc1ccoc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 2/20 0.52
TRPM8 Q7Z2W7 1/20 0.46
CTSB P07858 3/20 0.46
TACR1 P25103 4/20 0.42
CYP3A4 P08684 3/20 0.42
MEN1 O00255 1/20 0.42
SLC22A2 O15244 1/20 0.42
SLC22A1 O15245 1/20 0.42
ABCC3 O15438 1/20 0.42
ABCC4 O15439 1/20 0.42
MLNR O43193 1/20 0.42
NR1I2 O75469 1/20 0.42
SLCO2B1 O94956 1/20 0.42
ABCB11 O95342 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PGR P06401 1/20 0.42
ABCB1 P08183 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565848 1.00 CTRB1 (0.52) CTRB1TRPM8CTSBTACR1CYP3A4
SCHEMBL7337249 0.92 CYP3A4 (0.55) CTRB1CTSBTACR1CYP3A4MEN1
SCHEMBL7311195 0.92 CYP3A4 (0.55) CTRB1CTSBTACR1CYP3A4MEN1
SCHEMBL8606231 0.92 CYP3A4 (0.55) CTRB1CTSBTACR1CYP3A4MEN1
SCHEMBL7299634 0.90 CTRB1 (0.51) CTRB1TRPM8CTSBTACR1CYP3A4
SCHEMBL7299994 0.89 TRPM8 (0.46) CTRB1TRPM8CTSBTACR1CTSL
SCHEMBL4950328 0.89 CTRB1 (0.65) CTRB1TRPM8CTSBTACR1CYP3A4
SCHEMBL9005101 0.84 CYP3A4 (0.51) CTSBCYP3A4CTSLKLK5
SCHEMBL7298842 0.83 CTRB1 (0.50) CTRB1TRPM8CTSBTACR1CYP3A4
SCHEMBL7308773 0.83 CTRB1 (0.49) CTRB1TRPM8CTSBTACR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed